CLINICAL_TRIALS
research
· 2026-04-13
Clinical Trial Update: An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD) [Phase 2]
Summary
Phase 2 exploratory study sponsored by Yale University to test whether manipulating the immune system can prevent the emergence of synucleinopathy-related manif…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Yale University | Conditions: REM Sleep Behavior Disorder | Phase 2 | Status: NOT_YET_RECRUITING